Clinical Trials Directory

Trials / Unknown

UnknownNCT02293759

Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency

Prospective Non-randomized Trial Comparing Holmium Laser Enucleation of the Prostate Versus Greenlight Laser Photoselective Vaporization of the Prostate in Treating Benign Prostate Hyperplasia in Patients With Bleeding Tendency

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Male
Age
50 Years
Healthy volunteers
Not accepted

Summary

Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile. Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP

Detailed description

Elderly patients with bleeding tendency either secondary; 1. Strict antiplatelet intake 2. Strict anticoagulant intake 3. uncorrected natural bleeding tendency e.g; patients with liver cell failure are at higher risk of perioperative bleeding when subjected to prostate surgery. Laser prostate surery was introduced to overcome this difficulty. However, till now there is no head to head comparision of different types of laser procedures in treating this subset of patients In the current study patients presented for BPH surgery in a tertiarry referral prostate unit will be assessed for bleeding tendency and will be treated either by Holmium laser enucleatiuon of the prostate or Greenlight laser vaporization of the prostate Single surgeon will perform all cases

Conditions

Interventions

TypeNameDescription
PROCEDUREHoLEPHolmium laser enucleation of the prsotate
PROCEDUREGreenlight laser PVPGreenlight laser (532nm) Photoslective vaporization of the prostate

Timeline

Start date
2014-10-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2014-11-18
Last updated
2016-03-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02293759. Inclusion in this directory is not an endorsement.